BIOHARVEST SCIENCES INC.
BHST
Analytical Summary
BIOHARVEST SCIENCES INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.
3-Year Financial Trajectory
AnnualBullish Indicators
- Debt to EquityDebt to Equity is in the top quartile (lower is better)
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 40-F ↗ | FY 2024 Dec 31, 2024 40-F ↗ | FY 2023 Dec 31, 2023 40-F ↗ |
|---|---|---|---|
| Revenue Growth YoY (%) |
37.0%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+363%)
|
98.8%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+1135%)
|
— |
| EPS Growth YoY (%) |
25.0%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
14.0%
Fair
Fair
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
| Net Income Growth YoY (%) |
13.8%
Fair
Fair
Year-over-year change in net income |
-2.8%
Weak
Weak
Year-over-year change in net income |
— |
| Metric | FY 2025 Dec 31, 2025 40-F ↗ | FY 2024 Dec 31, 2024 40-F ↗ | FY 2023 Dec 31, 2023 40-F ↗ |
|---|---|---|---|
| Operating Margin (%) (%) |
-16.2%
Weak
↑
Weak
Improving
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-208%)
|
-27.7%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-285%)
|
-78.6%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-624%)
|
| Effective Tax Rate (%) (%) |
0.7%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.1%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
| Profit Margin (%) (%) |
-32.3%
Weak
↑
Weak
Improving
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-369%)
|
-51.3%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-527%)
|
-99.1%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-926%)
|
| FCF Margin (%) (%) |
-27.8%
Weak
↑
Weak
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-37.8%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-78.9%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
| FCF / Net Income (x) |
0.86x
Caution
↑
Caution
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.74x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.80x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | FY 2025 Dec 31, 2025 40-F ↗ | FY 2024 Dec 31, 2024 40-F ↗ | FY 2023 Dec 31, 2023 40-F ↗ |
|---|---|---|---|
| Return on Invested Capital (%) |
-21.8%
Weak
↑
Weak
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-525.2%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
67.1%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
| Return on Capital (%) (%) |
-11.7%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-28.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-66.4%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
| Return on Common Equity (%) (%) |
-43.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-392%)
|
— |
84.6%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+464%)
|
| Metric | FY 2025 Dec 31, 2025 40-F ↗ | FY 2024 Dec 31, 2024 40-F ↗ | FY 2023 Dec 31, 2023 40-F ↗ |
|---|---|---|---|
| Debt to Equity (x) |
0.01x
Excellent
↓
Excellent
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-99%)
|
2.94x
Weak
Weak
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+389%)
|
0.00x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-100%)
|
| Net Debt (USD) | $-22.88M | $1.51M | $-5.36M |
| Debt / EBITDA (x) |
-0.04x
Excellent
↑
Excellent
Improving
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
-0.68x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
0.00x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
Secondary lens
Benchmark Lens
Compare BHST against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare BHST against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for BHST
Debt to Equity is in the top quartile (lower is better)
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How BHST compares to all companies
Peer Comparison
BHST vs similar peers
Compare BHST with peers
Stack BHST against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 3 years · 3 quarters